The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Arcellx Inc (NASDAQ: ACLX) closed at $63.16 in the last session, down -5.73% from day before closing price of $67.00. In other words, the price has decreased by -$5.73 from its previous closing price. On the day, 0.74 million shares were traded. ACLX stock price reached its highest trading level at $66.81 during the session, while it also had its lowest trading level at $62.47.
Ratios:
We take a closer look at ACLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 954.01. For the most recent quarter (mrq), Quick Ratio is recorded 4.29 and its Current Ratio is at 4.29. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $109.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $70.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $70 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Patel Kavita sold 1,500 shares for $64.57 per share. The transaction valued at 96,855 led to the insider holds 0 shares of the business.
Patel Kavita sold 1,500 shares of ACLX for $98,801 on Jan 14 ’25. The Director now owns 0 shares after completing the transaction at $65.87 per share. On Jan 07 ’25, another insider, Heery Christopher, who serves as the CHIEF MEDICAL OFFICER of the company, sold 4,230 shares for $75.53 each. As a result, the insider received 319,485 and left with 28,638 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 3415357952 and an Enterprise Value of 2906434048. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.92 while its Price-to-Book (P/B) ratio in mrq is 7.06. Its current Enterprise Value per Revenue stands at 18.653 whereas that against EBITDA is -44.51.
Stock Price History:
The Beta on a monthly basis for ACLX is 0.29, which has changed by 0.039726853 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, ACLX has reached a high of $107.37, while it has fallen to a 52-week low of $47.88. The 50-Day Moving Average of the stock is -15.47%, while the 200-Day Moving Average is calculated to be -9.81%.
Shares Statistics:
According to the various share statistics, ACLX traded on average about 600.63K shares per day over the past 3-months and 523360 shares per day over the past 10 days. A total of 53.99M shares are outstanding, with a floating share count of 40.58M. Insiders hold about 24.95% of the company’s shares, while institutions hold 82.61% stake in the company. Shares short for ACLX as of 1738281600 were 7310112 with a Short Ratio of 11.15, compared to 1735603200 on 5809082. Therefore, it implies a Short% of Shares Outstanding of 7310112 and a Short% of Float of 15.479999999999999.
